(Q41503381)

English

Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus

scientific article published on 5 February 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

0 references

Hepatitis B virus

1 reference

based on heuristic

inferred from title

0 references

author name string

S Zhen

1

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

L Hua

2

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Y-H Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

L-C Gao

4

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

J Fu

5

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

D-Y Wan

6

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

L-H Dong

7

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

H-F Song

8

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

X Gao

9

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

5 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

404-412

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Hepatitis B virus-cell interactions and pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Durability of serologic response after lamivudine treatment of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Current treatment strategies for chronic hepatitis B and C.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Hepatitis B virus genome variability and disease progression: the impact of pre-core mutants and HBV genotypes

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Antiviral therapy and resistance with hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Occult HBV infection

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Control of cccDNA function in hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Highly efficient endogenous human gene correction using designed zinc-finger nucleases

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Efficient and specific modifications of the Drosophila genome by means of an easy TALEN strategy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Heritable gene targeting in zebrafish using customized TALENs.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

The discovery of zinc fingers and their applications in gene regulation and genome manipulation.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

RNA-guided human genome engineering via Cas9

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Genome-scale engineering for systems and synthetic biology

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Targeted DNA mutagenesis for the cure of chronic viral infections

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Homing endonucleases: structure, function and evolution

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Artificial DNA cutters for DNA manipulation and genome engineering

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

TALENs: a widely applicable technology for targeted genome editing

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Efficient genome editing in zebrafish using a CRISPR-Cas system

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Multiplex genome engineering using CRISPR/Cas systems

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Repeatable construction method for engineered zinc finger nuclease based on overlap extension PCR and TA-cloning

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Efficient generation of large-scale genome-modified mice using gRNA and CAS9 endonuclease

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Hepatitis B virus is inhibited by RNA interference in cell culture and in mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Improving CRISPR-Cas nuclease specificity using truncated guide RNAs

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Presence and state of woodchuck hepatitis virus DNA in liver and serum of woodchucks: further analogies with human hepatitis B virus

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

A rapid and general assay for monitoring endogenous gene modification

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Preliminary study on the efficacy and safety of lamivudine and interferon alpha therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.2

21 January 2018

Primary hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of hepatitis B viral replication and proteomic analysis of HepG2.2.15 cell line after knockdown of HBx.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The knockout rat pack

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure of the hepatitis B virus genome

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishment of mice model with human viral hepatitis B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure and expression of the hepatitis B virus genome

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular virology and pathogenesis of hepatitis B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Woodchuck hepatitis virus X protein is required for viral infection in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of mutant mice by pronuclear injection of circular plasmid expressing Cas9 and single guided RNA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virus-infected liver.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Knockout mice created by TALEN-mediated gene targeting

1 reference

https://pubmed.ncbi.nlm.nih.gov/25652100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/GT.2015.2

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Dimensions Publication ID

0 references

release_jgrsssa2bzbb5ln4szyqers6ru

1 reference

https://api.fatcat.wiki/v0/release/jgrsssa2bzbb5ln4szyqers6ru

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41503381&oldid=2204586372"